Fundraise during UK Diabetes Week
Calling all UK-based creators! Join us 9–15 June to support Breakthrough T1D UK.
Breakthrough T1D publishes ambitious 10-year strategy to accelerate type 1 diabetes care
We have launched a new 10-year strategy aimed at driving significant advancements in type 1 diabetes (T1D) research, treatment, and care.
Making medical research programmes and clinical trials more accessible and inclusive
Read our top takeaways from the "Recruiting to medical research programmes and trials — how can we be smarter and more equitable?" webinar.
Novo Nordisk to discontinue Levemir insulin by end of 2026
Novo Nordisk will stop producing Levemir insulin next year but there are plans in place to help you transition to an alternative.
